Hypomagnesaemic tetany associated with repeated courses of intravenous tobramycin in a patient with cystic fibrosis

被引：6
|
作者：
Adams, JP [1 ]
Conway, SP [1 ]
Wilson, C [1 ]
机构：
[1] Seacroft Hosp, Reg Adult Cyst Fibrosis Ctr, Leeds LS14 6UH, W Yorkshire, England
来源：
RESPIRATORY MEDICINE | 1998年 / 92卷 / 03期
关键词：
D O I：
10.1016/S0954-6111(98)90319-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：602 / 604
页数：3
相关论文
共 50 条
  • [21] Oral Azithromycin and Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis
    Klingel, Michelle
    Stanojevic, Sanja
    Tullis, Elizabeth
    Ratjen, Felix
    Waters, Valerie
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (07) : 861 - 867
  • [22] Pharmacokinetics of once and twice daily dosing of intravenous tobramycin in paediatric patients with cystic fibrosis
    Turner, R. Brigg
    Elbarbry, Fawzy
    Biondo, Lisa
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (04) : 304 - 307
  • [23] Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin
    Lipp, Madeline A.
    Crass, Ryan L.
    Fitzgerald, Linda J.
    Patel, Twisha S.
    Simon, Richard H.
    Lenhan, Blair E.
    Han, MeiLan K.
    Jia, Shijing
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (09) : 2516 - 2521
  • [24] EMERGENCE OF LINEZOLID- RESISTANT STAPHYLOCOCCUS AUREUS ASSOCIATED WITH REPEATED COURSES IN ADULT AND PEDIATRIC CYSTIC FIBROSIS PATIENTS
    Andricopulos, K.
    Rybak, J. M.
    Osborne, S.
    Burgess, D.
    Danov, Z.
    Kuhn, R.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 331 - 332
  • [25] Incidence of cochleotoxicity in cystic fibrosis patients receiving repeated courses of aminoglycoside therapy
    Mulheran, M
    Hyman-Taylor, P
    Diver, C
    Tan, K
    Knox, A
    Stableforth, D
    Smyth, A
    THORAX, 2000, 55 : A75 - A75
  • [26] CUMULATIVE AND ACUTE TOXICITY OF REPEATED HIGH-DOSE TOBRAMYCIN TREATMENT IN CYSTIC-FIBROSIS
    PEDERSEN, SS
    JENSEN, T
    OSTERHAMMEL, D
    OSTERHAMMEL, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) : 594 - 599
  • [27] Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder
    Greenberg, Jonathan
    Palmer, Jacqueline B.
    Chan, Wing W.
    Correia, Catherine E.
    Whalley, Diane
    Shannon, Paul
    Sawicki, Gregory S.
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 2163 - 2169
  • [28] Fever associated with intravenous antibiotics in adults with cystic fibrosis
    Mallon, P
    Murphy, P
    Elborn, S
    LANCET, 1997, 350 (9092): : 1676 - 1677
  • [29] Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosis
    Touw, DJ
    Vinks, AATMM
    Heijerman, HGM
    Bakker, W
    THERAPEUTIC DRUG MONITORING, 1996, 18 (02) : 118 - 123
  • [30] ACUTE KIDNEY INJURY IN CYSTIC FIBROSIS PATIENTS TREATED WITH INTRAVENOUS COLISTIMETHATE SODIUM VERSUS TOBRAMYCIN
    Lipp, M.
    Crass, R.
    Fitzgerald, L.
    Patel, T.
    Labaki, W.
    Jia, S.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S375 - S375
12345